Genetic investigation of non-affective psychosis and depression as causal risk factors for dementia

• by Valentina Escott-Price, Emily Simmonds, Michael J Owen, Michael O’Donovan

• June 24, 2026

Evaluation of a hybrid asynchronous-synchronous delivery model for family intervention in psychosis: the psychosis REACH program

• by Sarah L. Kopelovich, Jennifer Blank, Akansha Vaswani-Bye, Victoria Shepard, Helen Teresa Buckland, Kate Hardy, Douglas Turkington

• July 21, 2026

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min

Digital Mental Health Treatment and Symptoms of Depression and Anxiety in Breast Cancer Survivors: A

• by Philip I. Chow, Wen You, Kelly M. Shaffer, Wendy F. Cohn, Shayna L. Showalter, Cynthia Orange, Lee M. Ritterband, David C. Mohr

• July 20, 2026